SPO Global Inc. announces a partnership between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group), a subsidiary of Gerbang Medical

SPO Global Inc.

SPO Global Inc. announces partnership between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group)

Cinuo Chinese Medicine Science and Technology Group Co.- intelligent decoding equipment

Cinuo Chinese Medicine Science and Technology Group Co.- intelligent decoding equipment

SPO Global Inc. announces partnership between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group)

Cinuo Chinese Medicine Science and Technology Group Co.- Traditional Chinese Medicine

Cinuo Chinese Medicine Science and Technology Group Co.- Traditional Chinese Medicine

SPO Global Inc. announces partnership between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group)

Cinuo Chinese Medicine Science and Technology Group Co. - Intelligent Automatic Chinese Medicine Equipment

Cinuo Chinese Medicine Science and Technology Group Co. – Intelligent Automatic Chinese Medicine Equipment

Shandong, China, March 29, 2022 (GLOBE NEWSWIRE) — SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotechnology company, today announced a partnership between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group), a subsidiary of Gerbang Medical.

On March 24, 2022, Mr. Lu Fengyou, Chairman of Shandong SPO Medical (Group) Co., Ltd., a subsidiary of Gerbang Medical Group, met with Mr. Zhangjie, Chairman of Cinuo Chinese Medicine Technology Group Co., Ltd., and reached a strategic agreement on the future development of the establishment of a Chinese medicine substitution intelligent center.

The Jinan Project Center serves 500 medical institutions. The investment is 12 million RMB, the annual output value is about 80 million RMB, and the annual net profit is 16 million RMB. The project covers five business segments: Ancient Chinese Medicine Achievement Research and Processing, Online Chinese Medicine Specialty Hospital, Yi Jiankang Intelligent Platform, Intelligent Decoction Equipment, and Planting Project intelligent Chinese herbal medicine. Keeping sophisticated and intelligent medical care in mind and keeping pace with the times, the creation of the “internet plus” model will help modernize traditional Chinese medicine.

Cinuo Chinese Medicine Science and Technology Group Co., Ltd. is a large-scale modern Chinese medicine science and technology innovation enterprise integrating scientific research, production, processing and marketing departments. The company’s predecessor was the Shandong Cinuo Institute of Traditional Chinese Medicine. In order to accelerate the implementation of traditional Chinese medicine scientific and technological innovation to stimulate economic development, Cinuo Group established a technology research and development center.

Relying on the strong technical force and platform advantages of Traditional Chinese Medicine University School of Pharmacy, a series of related products have been developed and completed, which are applied to research and Chinese medicine automatic intelligent equipment development, Chinese medicine purification, disease risk assessment and Chinese medical data wisdom. Strategic cooperation agreements have been signed with the Institute of Traditional Chinese Medicine and the University of Traditional Chinese Medicine.

Lu Fengyou, chairman of SPO Medical Group, expressed the hope that in the future, he will cooperate in depth with Cinuo Chinese Medicine Science and Technology Group to jointly build a Chinese medicine substitution service that can provide residents local, practical and fast services. It also hopes to build an e-health Chinese medicine R&D and innovation center, which will be divided into four major areas, including the Chinese medicine intelligent system platform and the product R&D achievements transformation station. , a laboratory with modern equipment, as well as an institute. genetic selection of traditional Chinese medicine plants. This would set a new benchmark for Chinese medicine centers in Shandong.

“In 2022, through the strategic cooperation of both sides, we will strive to summarize the concept of building ‘intelligent Chinese medicine’ in Jinan as ‘one center, four systems and several systematic projects’, which is also the core of the smart medical solutions in China,” Mr. Fengyou said.

We encourage our shareholders to visit our corporate Twitter account for more updates: https://twitter.com/spo_global

About SPO Global Inc. (OTC Pink: SPOM): SPO Global Inc. recently completed its merger with Gerpang Healthcare Group. (www.gerpanghealthcare.com). Its subsidiary, Shandong Gerpang Biotechnology Co., Ltd. is an innovative and technological private enterprise located in Pharmaceutical Valley Industrial Park of Jinan High Tech Zone. Its main business scope includes biomedical R&D, development and sales of medical information software, introduction of high medical technology, production and sales of high quality medical consumables, health care products, medicines, the agency and the sale of consumables for medical equipment.

Company Disclaimer: As a publicly traded company, pursuant to federal and state securities law guidelines, SPO Global, Inc. cannot rely on safe harbor provisions such as ‘identified in the Private Securities Litigation Reform Act of 1995. However, SPO Global, Inc. provides the following disclaimer and warning to protect our shareholders, potential investors and the general public by alerting them to the risks and the uncertainties associated with any investment, and the need to carry out their own due diligence and evaluation.

Forward-Looking Statements: This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are therefore forward-looking. Forward-looking statements include all statements that are not statements of historical fact regarding the current intention, belief or expectations of the Company, its directors or its officers. Investors are cautioned that these forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those set forth in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances generally, including the ability to pursue and manage its growth. , competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission.

Company Contact: [email protected]

Source: SPO Global Inc.

Attachments